BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

AVET PHARMACEUTICALS — Lobbying — Receipts Report

LD-2 disclosure · 4th Quarter - Amendment

AVET PHARMACEUTICALS

via RUBICON ADVISORS, LLC

4th Quarter (Oct 1 - Dec 31) · 2019Posted Sept 29, 2020Filing document ↗LDA record ↗

Income$30Kfee reported

Client

Name: AVET PHARMACEUTICALS
Description: Sells Generic Pharmaceuticals
Location: New Jersey · United States of America

Registrant

Firm: RUBICON ADVISORS, LLC
Description: Lobbying firm
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Pharmacy
GENERIC DRUG PRICING,HOUSE COMMITTEE ON OVERSIGHT,GOVERNMENT REFORM AND COVID-19 FDA DRUG SHORTAGES
LobbyistsKATHY KULKARNI · WILLIAM BURKE
TargetedHOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.